Document is current
Any future updates will be listed below
-
Authors
Ma, Huangrong
Ma, Lingyu
Yang, Li
Cai, Miaoying
Wang, Yifu
Li, Yue
Liang, Chunyu
Xu, Zhiyuan
-
Funding
Funding for this research was provided by:
Shenzhen Science and Technology Innovation Program (No.JCYJ20210324114600002, No.JCYJ20210324114600002, No.JCYJ20210324114600002, No.JCYJ20210324114600002, No.JCYJ20210324114600002, No.JCYJ20210324114600002)
Cultivation Program of Independent Innovation Achievements for Graduate Students of Shenzhen University
Shenzhen Key Laboratory for cancer metastasis and personalized therapy (No.ZDSYS20210623091811035, No.ZDSYS20210623091811035)
- License Information
-
More Information
Article History
Received: 25 September 2024
Accepted: 24 January 2025
First Online: 5 February 2025
Declarations
:
: The formulation of the experimental protocol complies with the ethical guidelines of the Helsinki Declaration and has been approved by the Medical Ethics Committee of The University of Hong Kong - Shenzhen Hospital ([2022]020). Individual consent from each patient for this retrospective analysis was waived.
: The authors declare no competing interests.
